BeStock  

Takeda Pharmaceutical TAK

US equityMarket cap rank #310Infectious Disease
$21.77 +$0.36 (+1.68%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $22.09 +1.47%
Open$21.82
Prev close$21.41
Day range$21.74 – $22.07
Volume3.80M
Market cap$69.76B
P/E (TTM)311.0
Dividend yield1.44%

Valuation

Multiples measured against the stock's own five-year history

Price / earnings306.1x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 40.0x

#2946 of 2993 stocks by PE (1 = cheapest)

Price / book1.2x
CheapRich

Near the top of its 5-year range · 95th percentile, 5-year average 1.0x

#1621 of 5316 stocks by PB (1 = cheapest)

Price / sales2.3x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 1.6x

#2757 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-89x54x197x341xSep '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$21.02
Price vs. fair value+3.6%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyLow
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.19 – 0.99 95% (pricier than usual) #1621 of 5316 (1 = cheapest)
PE 306.14 39.28 40.04 100% (pricier than usual) #2946 of 2993 (1 = cheapest)
PS 2.34 2.30 1.65 100% (pricier than usual) #2757 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TAK.

Sign in to join the discussion.

Scroll to Top